QI
SGMO

QS Investors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

QS Investors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$442K Hold
36,900
– – 0.01% 791
2021
Q1 		$463K Sell
36,900
-700
-2% -$9.43K 0.01% 831
2020
Q4 		$587K Buy
37,600
+11,292
+43% +$132K 0.01% 706
2020
Q3 		$249K Sell
26,308
-98,281
-79% -$1.06M ﹤0.01% 997
2020
Q2 		$1.12M Hold
124,589
– – 0.02% 691
2020
Q1 		$794K Hold
124,589
– – 0.01% 730
2019
Q4 		$1.02M Sell
124,589
-2,750
-2% -$25.3K 0.01% 774
2019
Q3 		$1.15M Hold
127,339
– – 0.01% 739
2019
Q2 		$1.37M Sell
127,339
-3,574
-3% -$38K 0.01% 709
2019
Q1 		$1.25M Sell
130,913
-734
-0.6% -$7.5K 0.01% 754
2018
Q4 		$1.51M Hold
131,647
– – 0.02% 657
2018
Q3 		$2.23M Hold
131,647
– – 0.02% 589
2018
Q2 		$1.87M Buy
131,647
+12
+0% +$199 0.02% 623
2018
Q1 		$2.5M Sell
131,635
-9,786
-7% -$209K 0.03% 501
2017
Q4 		$2.32M Sell
141,421
-594
-0.4% -$8.84K 0.02% 558
2017
Q3 		$2.13M Sell
142,015
-3,221
-2% -$35.6K 0.02% 588
2017
Q2 		$1.28M Hold
145,236
– – 0.01% 708
2017
Q1 		$755K Hold
145,236
– – 0.01% 861
2016
Q4 		$443K Hold
145,236
– – ﹤0.01% 910
2016
Q3 		$672K Hold
145,236
– – 0.01% 831
2016
Q2 		$841K Hold
145,236
– – 0.01% 804
2016
Q1 		$879K Hold
145,236
– – 0.01% 800
2015
Q4 		$1.33M Hold
145,236
– – 0.01% 742
2015
Q3 		$819K Hold
145,236
– – 0.01% 818
2015
Q2 		$1.61M Hold
145,236
– – 0.02% 660
2015
Q1 		$2.28M Hold
145,236
– – 0.03% 569
2014
Q4 		$2.21M Buy
+145,236
New +$1.76M 0.03% 563

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QS Investors's SGMO Position: Q2 2021 in Review

QS Investors held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q2 2021 at 36,900 shares worth $442K. The position accounts for 0.01% of the portfolio, ranked #791.

QS Investors first reported a position in SGMO in Q4 2014 and has held it in 27 quarters since. The position peaked at $2.5M in Q1 2018. 197 funds tracked by Wall St. Rank hold SGMO as of Q2 2021.

  • QS Investors held 36,900 shares of SANGAMO THERAPEUTICS INC worth $442K as of Q2 2021.
  • QS Investors left its SANGAMO THERAPEUTICS INC share count unchanged in Q2 2021.
  • SANGAMO THERAPEUTICS INC made up 0.01% of QS Investors's portfolio in Q2 2021, its #791 holding.
  • QS Investors first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and has held it in 27 quarters since.
  • QS Investors's SANGAMO THERAPEUTICS INC position peaked at $2.5M in Q1 2018.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.